DL-α-Methoxyphenylacetic acid

98%

Reagent Code: #169687
label
Alias O-methyl-DL-mandelic acid;
fingerprint
CAS Number 7021-09-2

science Other reagents with same CAS 7021-09-2

blur_circular Chemical Specifications

scatter_plot Molecular Information
Weight 166.17 g/mol
Formula C₉H₁₀O₃
badge Registry Numbers
EC Number 230-300-9
MDL Number MFCD00064217
thermostat Physical Properties
Melting Point 69-71 °C(lit.)
Boiling Point 165 °C18 mm Hg(lit.)
inventory_2 Storage & Handling
Storage Room temperature

description Product Description

Used primarily in the pharmaceutical industry as a chiral resolving agent to separate enantiomers of racemic mixtures, especially in the production of optically active drugs. Its ability to form diastereomeric salts with racemic amines allows for effective separation through crystallization. Commonly applied in the synthesis of active pharmaceutical ingredients (APIs) where stereochemistry impacts drug efficacy and safety. Also employed in asymmetric synthesis and development of chiral intermediates for antibiotics, antivirals, and cardiovascular medications.

shopping_cart Available Sizes & Pricing

Size Availability Unit Price Quantity
inventory 5g
10-20 days ฿1,000.00
inventory 25g
10-20 days ฿4,400.00
inventory 100g
10-20 days ฿15,990.00
inventory 1g
10-20 days ฿340.00
inventory 500g
10-20 days ฿73,450.00

Cart

No products

Subtotal: 0.00
Total 0.00 THB
DL-α-Methoxyphenylacetic acid
No image available

Used primarily in the pharmaceutical industry as a chiral resolving agent to separate enantiomers of racemic mixtures, especially in the production of optically active drugs. Its ability to form diastereomeric salts with racemic amines allows for effective separation through crystallization. Commonly applied in the synthesis of active pharmaceutical ingredients (APIs) where stereochemistry impacts drug efficacy and safety. Also employed in asymmetric synthesis and development of chiral intermediates for

Used primarily in the pharmaceutical industry as a chiral resolving agent to separate enantiomers of racemic mixtures, especially in the production of optically active drugs. Its ability to form diastereomeric salts with racemic amines allows for effective separation through crystallization. Commonly applied in the synthesis of active pharmaceutical ingredients (APIs) where stereochemistry impacts drug efficacy and safety. Also employed in asymmetric synthesis and development of chiral intermediates for antibiotics, antivirals, and cardiovascular medications.

Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...